Drug details

Nulojix (belatacept)

type of Immunosuppressants, Selective T-Cell Costimulation Blockers

Nulojix (belatacept) is a selective T-cell costimulation blocker indicated for the prevention of organ rejection in adult patients receiving a kidney transplant (not approved for other organ transplants). Nulojix is approved for use with other immunosuppressants (medications that suppress the immune system) and corticosteroids.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• vomiting,
• diarrhea,
• fever,
• swollen glands,
• night sweats,
• pale skin,
• cold hands and feet,
• weight loss,
• stomach pain,
• chest pain,
• fluttering in your chest,
• constipation,
• weakness,
• unusual tiredness,
• flu symptoms,
• little or no urination,
• irregular heartbeats,
• increased thirst or urination,
• memory problems,
• tingly feeling,
• leg cramps,
• decreased vision,
• blood in your urine,
• loss of movement,
• muscle weakness, and
• limp feeling
• burning when you urinate,
• weakness on one side of your body,
• problems with speech or walking,
• changes in your mental state,
• tenderness around the transplanted kidney,
• new skin lesion,
• mole that has changed in size or color,
• lightheaded,

The following drugs are related to Nulojix, either as a replacement or used together:

• Azasan (azathioprine)
• Imuran (azathioprine)